As the deadline for compliance with the EU FMD gets nearer, Manfred Voglmaier, VP DACH (Germany, Austria, Switzerland) sales, TraceLink, looks at how master data management framework can help businesses meet the necessary requirements.
In this online exclusive, Alex Aves, marketing executive, Rephine, looks at blockchain in more detail including how it may benefit the pharmaceutical sector.
The industry’s largest survey on serialisation readiness, including data from 660 respondents in the pharma supply chain, has been published by TraceLink.
In a new survey of European and North American companies Mettler Toledo PCE has revealed the importance of serialisation in the fight against counterfeiting.
Today (Friday 9 Feburary 2018) marks the precise point that we are a year away until the European Union Falsified Medicines Directive (EU FMD) comes into force. Here, we feature some expert opinions
Here, Dan Anslow, UK sales manager, Crest Solutions, shares some key tips and insights, learned through partnering with pharmaceutical manufacturers that have already successfully implemented solutions for serialisation, aggregation and Track & Trace
Jean-Marie Aulnette, vice president of EMEA Sales, TraceLink, reveals his thoughts on the challenges, opportunities and trends experienced over the course of the past 12 months.
Dexter Tjoa, director of corporate strategy, Tjoapack, discusses what he has found challenging and highlights the opportunities he has experienced for the year.
Today (Monday 27 November) marks the original deadline date for the DSCSA. While the FDA has delayed its enforcement of compliance with these serialisation requirements by a year, pharma is still required to legally comply. Industry tells us more…
Here, Mario Scigliano, serialisation & automation manager, and Christian Ahlmark, associate director, sales & key account management, CordenPharma, discuss how a CDMO can help give companies a fighting chance to be globally serialisation compliant.
Savvy pharma companies will use the US DSCSA enforcement postponement
for enhanced — not deferred — implementation of track & trace systems. Dave Harty, head of Professional Services for Adents, tells us more…
